Silver-nanoparticle-mediated therapies in the treatment of pancreatic cancer

Rachel Foulkes, Mohsen Ali Asgari, Anthony Curtis, Clare Hoskins

Research output: Contribution to journalReview article

Abstract

Pancreatic cancer is an extremely aggressive disease for which patient prognosis is poor and survival is extremely unlikely. It is an extremely under-represented cancer in the research field because of the dense tumors formed and complexities surrounding treatment requirements. The use of nanomedicines in cancer therapy has been explored over the past few decades. Such nanomedicines are slowly coming to fruition in the clinical setting. One such platform that may possess promise in the fight against pancreatic cancer is the use of colloidal silver. Silver nanoparticles have shown potential in other cancer types over a host of treatment strategies, and these are likely to be translatable into pancreatic cancer. This review will focus on the potential use of silver nanoparticles in pancreatic cancer therapy, reporting on a range of different strategies being employed that may be directly applicable in the improvement of clinical outcomes for pancreatic cancer patients.
Original languageEnglish
Pages (from-to)1758-1772
Number of pages15
JournalACS Applied Nano Materials
Volume2
Issue number4
DOIs
Publication statusPublished - 12 Mar 2019

Fingerprint

Pancreatic Neoplasms
Silver
Nanoparticles
Nanomedicine
Neoplasms
Therapeutics
Survival
Research

Keywords

  • pancreatic cancer
  • silver nanoparticles
  • cancer therapy
  • thermal therapy
  • antimicrobial
  • drug delivery

Cite this

Foulkes, R., Ali Asgari, M., Curtis, A., & Hoskins, C. (2019). Silver-nanoparticle-mediated therapies in the treatment of pancreatic cancer. ACS Applied Nano Materials, 2(4), 1758-1772. https://doi.org/10.1021/acsanm.9b00439
Foulkes, Rachel ; Ali Asgari, Mohsen ; Curtis, Anthony ; Hoskins, Clare. / Silver-nanoparticle-mediated therapies in the treatment of pancreatic cancer. In: ACS Applied Nano Materials. 2019 ; Vol. 2, No. 4. pp. 1758-1772.
@article{57a62b78b6634786bfe11d580fb9c7be,
title = "Silver-nanoparticle-mediated therapies in the treatment of pancreatic cancer",
abstract = "Pancreatic cancer is an extremely aggressive disease for which patient prognosis is poor and survival is extremely unlikely. It is an extremely under-represented cancer in the research field because of the dense tumors formed and complexities surrounding treatment requirements. The use of nanomedicines in cancer therapy has been explored over the past few decades. Such nanomedicines are slowly coming to fruition in the clinical setting. One such platform that may possess promise in the fight against pancreatic cancer is the use of colloidal silver. Silver nanoparticles have shown potential in other cancer types over a host of treatment strategies, and these are likely to be translatable into pancreatic cancer. This review will focus on the potential use of silver nanoparticles in pancreatic cancer therapy, reporting on a range of different strategies being employed that may be directly applicable in the improvement of clinical outcomes for pancreatic cancer patients.",
keywords = "pancreatic cancer, silver nanoparticles, cancer therapy, thermal therapy, antimicrobial, drug delivery",
author = "Rachel Foulkes and {Ali Asgari}, Mohsen and Anthony Curtis and Clare Hoskins",
note = "This document is the Accepted Manuscript version of a Published Work that appeared in final form in ACS Applied Nano Materials, copyright {\circledC} American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see https://doi.org/10.1021/acsanm.9b00439.",
year = "2019",
month = "3",
day = "12",
doi = "10.1021/acsanm.9b00439",
language = "English",
volume = "2",
pages = "1758--1772",
number = "4",

}

Foulkes, R, Ali Asgari, M, Curtis, A & Hoskins, C 2019, 'Silver-nanoparticle-mediated therapies in the treatment of pancreatic cancer', ACS Applied Nano Materials, vol. 2, no. 4, pp. 1758-1772. https://doi.org/10.1021/acsanm.9b00439

Silver-nanoparticle-mediated therapies in the treatment of pancreatic cancer. / Foulkes, Rachel ; Ali Asgari, Mohsen; Curtis, Anthony; Hoskins, Clare.

In: ACS Applied Nano Materials, Vol. 2, No. 4, 12.03.2019, p. 1758-1772.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Silver-nanoparticle-mediated therapies in the treatment of pancreatic cancer

AU - Foulkes, Rachel

AU - Ali Asgari, Mohsen

AU - Curtis, Anthony

AU - Hoskins, Clare

N1 - This document is the Accepted Manuscript version of a Published Work that appeared in final form in ACS Applied Nano Materials, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see https://doi.org/10.1021/acsanm.9b00439.

PY - 2019/3/12

Y1 - 2019/3/12

N2 - Pancreatic cancer is an extremely aggressive disease for which patient prognosis is poor and survival is extremely unlikely. It is an extremely under-represented cancer in the research field because of the dense tumors formed and complexities surrounding treatment requirements. The use of nanomedicines in cancer therapy has been explored over the past few decades. Such nanomedicines are slowly coming to fruition in the clinical setting. One such platform that may possess promise in the fight against pancreatic cancer is the use of colloidal silver. Silver nanoparticles have shown potential in other cancer types over a host of treatment strategies, and these are likely to be translatable into pancreatic cancer. This review will focus on the potential use of silver nanoparticles in pancreatic cancer therapy, reporting on a range of different strategies being employed that may be directly applicable in the improvement of clinical outcomes for pancreatic cancer patients.

AB - Pancreatic cancer is an extremely aggressive disease for which patient prognosis is poor and survival is extremely unlikely. It is an extremely under-represented cancer in the research field because of the dense tumors formed and complexities surrounding treatment requirements. The use of nanomedicines in cancer therapy has been explored over the past few decades. Such nanomedicines are slowly coming to fruition in the clinical setting. One such platform that may possess promise in the fight against pancreatic cancer is the use of colloidal silver. Silver nanoparticles have shown potential in other cancer types over a host of treatment strategies, and these are likely to be translatable into pancreatic cancer. This review will focus on the potential use of silver nanoparticles in pancreatic cancer therapy, reporting on a range of different strategies being employed that may be directly applicable in the improvement of clinical outcomes for pancreatic cancer patients.

KW - pancreatic cancer

KW - silver nanoparticles

KW - cancer therapy

KW - thermal therapy

KW - antimicrobial

KW - drug delivery

U2 - 10.1021/acsanm.9b00439

DO - 10.1021/acsanm.9b00439

M3 - Review article

VL - 2

SP - 1758

EP - 1772

IS - 4

ER -

Foulkes R, Ali Asgari M, Curtis A, Hoskins C. Silver-nanoparticle-mediated therapies in the treatment of pancreatic cancer. ACS Applied Nano Materials. 2019 Mar 12;2(4):1758-1772. https://doi.org/10.1021/acsanm.9b00439